Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders.
Imwaqqfa fis-sena
2020
Dħul
$500K - $1.0M
Finanzjament
Mhux magħruf
Ara kumpaniji simili
Qualify this Company in
minutes
Filwaqt li għodod oħra jaħlulek il-ħin, aħna ngħinuk tikkwalifika kumpaniji li jaqblu aħjar fi ftit minuti, biex il-pipeline tiegħek jibqa' b'saħħtu, it-tim tiegħek jibqa' produttiv, u d-deals jimxu aktar malajr.
Ibda l-Prova Bla Ħlas ta' 7 Ijiem
